Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > EU backs curbs on Chinese medical device firms in public tenders
    Headlines

    EU backs curbs on Chinese medical device firms in public tenders

    Published by Global Banking & Finance Review®

    Posted on June 2, 2025

    3 min read

    Last updated: January 23, 2026

    EU backs curbs on Chinese medical device firms in public tenders - Headlines news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:public procurementEuropean CommissionInternational trade

    Quick Summary

    The EU proposes restrictions on Chinese medical device suppliers in public tenders to ensure fair access for EU companies, sparking trade tensions.

    EU Proposes Restrictions on Chinese Medical Device Suppliers in Tenders

    BRUSSELS (Reuters) -European Union governments have backed a proposal to limit Chinese medical device suppliers' participation in bids for public contracts, after finding EU companies were not given fair access to China's public tenders, EU diplomats said on Monday.

    The measures proposed by the European Commission will be the first under the EU's International Procurement Instrument, which is designed to ensure reciprocity, after the Commission launched an investigation in April 2024.

    Under the instrument, the EU executive can exclude Chinese bidders from larger EU public procurement tenders or attach a penalty score to their bids for five years to tackle discrimination.

    The European Commission confirmed it put a proposal to EU members on Monday but said it could not disclose the outcome of the vote, the content of its proposal or its next steps.

    Under EU law, any measures must be "proportionate."

    The Commission has previously said it found "clear evidence" that China favoured Chinese devices for hospitals and its tender conditions led to abnormally low bids that profit-oriented companies could not offer.

    The new restrictions are likely to increase tensions inflamed by EU tariffs on China-built electric vehicles and Chinese measures against EU brandy.

    EU Trade Commissioner Maros Sefcovic was due to meet Chinese Commerce Minister Wang Wentao in Paris on Tuesday, according to Sefcovic's agenda.

    China called on the EU to follow through on its commitment to an open market, and be fair and transparent to Chinese firms.

    "The EU has always claimed to be the most open market in the world, but in fact, it is moving step by step towards protectionism," Chinese foreign ministry spokesperson Lin Jian told reporters at a regular news briefing on Tuesday.

    The China Chamber of Commerce to the EU expressed "profound disappointment" about the decision, which it said failed to acknowledge the significant access European medical device firms had enjoyed in China.

    "At a time when the global trade faces considerable uncertainty, and certain countries are resorting to unilateral tariff measures that disrupt global market order, China and the EU... should jointly uphold free trade," it said.

    A Commission investigation published in January found 87% of a sample of Chinese public tenders contained direct and indirect restrictions on imported devices. It also said explicit bans on imported devices in Chinese tenders rose from 2022 to 2024.

    Restrictions primarily affected ear, nose and throat devices, such as those used to clear airways, general diagnostic devices and diagnostic imaging devices.

    The Commission said China had not proposed any corrective action to remedy the situation. The two sides could still reach an agreement to avoid EU measures.

    (Reporting by Philip Blenkinsop; Additional reporting by Antoni Slodkowski in Beijing; Editing by Cynthia Osterman and Sonali Paul)

    Key Takeaways

    • •EU proposes limiting Chinese medical device suppliers in public tenders.
    • •The proposal aims to ensure fair access for EU companies in China.
    • •Measures are part of the EU's International Procurement Instrument.
    • •China criticizes the EU's move towards protectionism.
    • •EU and China may still reach an agreement to avoid restrictions.

    Frequently Asked Questions about EU backs curbs on Chinese medical device firms in public tenders

    1What proposal did the EU back regarding Chinese medical device suppliers?

    The EU governments backed a proposal to limit Chinese medical device suppliers' participation in public contract bids, aiming to ensure reciprocity in procurement.

    2What is the purpose of the International Procurement Instrument?

    The International Procurement Instrument is designed to ensure reciprocity in public procurement, allowing the EU to exclude Chinese bidders or penalize their bids for up to five years.

    3How has China responded to the EU's proposal?

    China has called on the EU to maintain an open market and criticized the EU for moving towards protectionism, expressing disappointment over the decision.

    4What evidence did the European Commission find regarding Chinese public tenders?

    The Commission found that 87% of a sample of Chinese public tenders contained restrictions on imported medical devices, indicating a lack of fair access for foreign suppliers.

    5What are the potential consequences of the new restrictions?

    The new restrictions could escalate tensions between the EU and China, particularly in light of existing trade disputes, such as EU tariffs on Chinese electric vehicles.

    More from Headlines

    Explore more articles in the Headlines category

    Image for Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Image for Trump says good talks ongoing on Ukraine
    Trump says good talks ongoing on Ukraine
    Image for France to rally aid for Lebanon as it warns truce gains remain fragile
    France to rally aid for Lebanon as it warns truce gains remain fragile
    Image for Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Olympics-Italy's president takes the tram in video tribute to Milan transport
    Olympics-Italy's president takes the tram in video tribute to Milan transport
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Image for Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    Image for UK police search properties in probe into Mandelson over Epstein ties
    UK police search properties in probe into Mandelson over Epstein ties
    View All Headlines Posts
    Previous Headlines PostTwo exiled Belarusian publishers share Prix Voltaire for defending their language and culture
    Next Headlines PostExclusive-US pushes countries for best offers by Wednesday as tariff deadline looms